Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00792233 · ClinicalTrials.gov registry record · Phase 4
Determining Predictors of Safe Discontinuation of Anti-TNF Treatment in JIA
A Phase 4 study, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- Phase 4
- Development phase
- 137
- Enrollment target
NCT00792233 is a Phase 4 study that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 137 participants.
The verdict
NCT00792233, a Phase 4 study, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 137 participants
- Enrollment target
Study Summary
Polyarticular juvenile idiopathic arthritis (Poly JIA) is a form of juvenile arthritis, which is a chronic disease affecting approximately 250,000 people younger than 16 years of age. Poly JIA can be treated with anti-tumor necrosis factor (anti-TNF), a type of medication that is often effective but also has some toxic side effects and is expensive. Among those with poly JIA who are effectively treated with anti-TNF, some can remain healthy off the medication, but some begin to feel the effects of their disease again once the medication is stopped. This study will attempt to find whether certain tests or signs can predict which people with poly JIA can safely stop their anti-TNF medications.
Interventions
- OTHER Withdrawal of anti-TNF therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 137 participants |
| Start Date | 2009-06 |
| Est. Completion | 2015-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00792233
The ClinicalTrials.gov registry entry for NCT00792233 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 137 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Withdrawal of anti-TNF therapy is the first listed.
NCT00792233 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00792233 about?
NCT00792233 is a clinical study titled "Determining Predictors of Safe Discontinuation of Anti-TNF Treatment in JIA". Polyarticular juvenile idiopathic arthritis (Poly JIA) is a form of juvenile arthritis, which is a chronic disease affecting approximately 250,000 people younger than 16 years of age. Poly JIA can be treated with anti-tumor necrosis factor (anti-TNF), a type of medication that is often effective but...
What is the current status of trial NCT00792233?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 137 participants. The study started on 2009-06. Estimated completion is 2015-10.
What interventions are being tested in trial NCT00792233?
The interventions under investigation include: Withdrawal of anti-TNF therapy (OTHER).
Who is sponsoring clinical trial NCT00792233?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.